Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: CUBBY who wrote (448)	3/10/1998 4:58:00 PM
From: BARRY ALLEN	Read Replies (1) \| Respond to of 4140

Tuesday March 10, 10:30 am Eastern Time Company Press Release SOURCE: The Red Chip Review The Red Chip Review Investor Conference Showcases Investment Opportunities in High-Performance Small-Cap Arena PORTLAND, Ore., March 9 /PRNewswire/ -- Fourteen of the fastest-growing publicly traded companies present their stories to the public on March 19 in Seattle, Washington, at a conference hosted by The Red Chip Review. ''This is a unique opportunity for individual investors to gain information on quality small-cap stocks directly from company management,'' said Marc Robins, editor-in-chief and publisher of The Red Chip Review, the event's sponsor. ''Most investor conferences are targeted for retail brokers and institutional money managers. The mission of The Red Chip Review is to make available to individual investors information that is generally available only to the profession.'' The Red Chip Review Investor Conference is scheduled from 8 a.m. to 5 p.m. at the Madison Hotel in downtown Seattle. Tickets are free for subscribers to The Red Chip Review, $89 for nonsubscribers. Admission includes a two-page comprehensive analysis, researched by Red Chip's expert analysts, on each of the 14 presenting companies, plus a healthy sit-down lunch, provided free by The Red Chip Review. At the March 19 conference, investors will meet the top executives from 14 of these promising companies that have made it through Red Chip's demanding selection criteria and tough objective analysis. Other companies presenting at the conference include: Sunrise Technologies, Inc. (OTC: SNRS - news) Red Chip Rating: B A little-known, ascending player in the multibillion-dollar refractive corrections sector of the ophthalmology market, SNRS has created a non-contact, laser-based system that simultaneously corrects farsightedness, nearsightedness and other vision problems. This system currently is in Phase III FDA clinical trials in the U.S. Visit their website at www.sunrise-tech.com. biz.yahoo.com